XML 57 R42.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Loss Before Income Taxes
Loss before income taxes consists of:
 For the Year Ended
December 31,
(In thousands)20242023
Domestic$(26,806)$(41,303)
Foreign420 (6,375)
Income before taxes$(26,386)$(47,678)
Schedule of Income Tax Reconciliation
The provision for income taxes differs from the amount computed by applying the statutory rate as follows:
 For the Year Ended
December 31,
(In thousands)20242023
Income taxes using U.S federal statutory rate$(5,541)$(10,012)
Nondeductible interest64 127 
Branch income151 (1,230)
State income taxes, net of federal benefit(1,513)(31)
Foreign rate differential(67)506 
Valuation allowance3,029 7,099 
Stock option expense, exercises and cancellations1,336 2,899 
Research and development costs(746)(859)
Other332 (179)
Derivative Charge2,955 1,680 
 $— $— 
Schedule of Significant Components of Deferred Tax Assets and Liabilities
Significant components of the Company’s deferred tax assets are as follows:
 For the Year Ended
December 31,
(In thousands)20242023
Deferred tax assets:
Employee compensation accruals$2,182 $1,377 
Accrued liabilities707 54 
Research tax credits3,015 2,330 
Lease obligation249 
Other171 233 
Research expense capitalization6,927 5,441 
Net operating losses29,071 29,875 
Total deferred tax assets$42,322 $39,314 
 For the Year Ended
December 31,
(In thousands)20242023
Deferred tax liabilities:
Right of use asset$249 $13 
Total deferred tax liabilities249 13 
Valuation allowance42,073 39,301 
Net deferred tax assets$— $— 
Schedule of Change in Valuation Allowance The change in valuation allowance is as follows:
 December 31,
(In thousands)20242023
Beginning Balance$39,301 $32,344 
Charged to costs and expenses3,028 7,099 
Charged to other comprehensive income(256)(142)
Ending balance$42,073 $39,301